Incyte Biosciences Germany GmbH is a 100% subsidiary of Incyte Biosciences International S.à r.l. and is included in the consolidated financial statements of Incyte Corporation. The company operates as a pure marketing entity and is responsible for marketing pharmaceutical products as well as conducting awareness and medical training campaigns for hospitals, physicians and pharmacists. Remuneration is based on an intercompany service agreement using a cost-plus method (mark-up 3.59% for 2024) and products commercially available in Germany are supplied via Incyte Biosciences Distribution B.V. (e.g., Opzelura, Pemazyre, Monjuvi/Minjuvi, Iclusig). In the 2024 financial year the company generated revenues of EUR 32,372,476 and employed on average 84 staff.
Verkauf, Vermarktung und Vertrieb pharmazeutischer Produkte sowie damit verbundene Forschung im Bereich der Biowissenschaften.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) München Local Court, HRB 230547 (as of 9 October 2026)
Source: German Commercial Register (Handelsregister) München Local Court, HRB 230547 (as of 9 October 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) München Local Court, HRB 230547 (as of 9 October 2026)
Sign in to view detailed salary and cost trends.
